Feilan Chen
Impact in
- Ophthalmology top 5%
- Ocular Diseases and Behçet’s Syndrome
-
- Glioma Diagnosis and Treatment
Papers in
-
- Ocular Diseases and Behçet’s Syndrome 11
- Genetics 2
- Glioma Diagnosis and Treatment 2
- Co-authors
- Zhaohua Tang (5 shared papers)Zili Liu (4 shared papers)Yongguo Li (1 shared paper)Yan Chen (1 shared paper)Jie Gao (1 shared paper)Shengping Hou (6 shared papers)Peizeng Yang (4 shared papers)Aize Kijlstra (3 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Journal of Neuro-Oncology (2 papers)Lara D. Veeken (1 paper)Cancer Cell International (1 paper)Arthritis Research & Therapy (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Feilan Chen
22 papers receiving 517 citations
Peers
Comparison fields: 5 of 74
- Ophthalmology 98
- Genetics 42
- Cancer Research 61
- Drug Discovery 1
- Biomaterials 43
Countries citing papers authored by Feilan Chen
This map shows the geographic impact of Feilan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilan Chen more than expected).
Fields of papers citing papers by Feilan Chen
This network shows the impact of papers produced by Feilan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilan Chen. The network helps show where Feilan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Feilan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 184 | |
| 2 | 2020 | 65 | |
| 3 | 2021 | 48 | |
| 4 | 2012 | 38 | |
| 5 | 2011 | 34 | |
| 6 | 2008 | 24 | |
| 7 | 2020 | 23 | |
| 8 | 2022 | 23 | |
| 9 | 2020 | 20 | |
| 10 | Polymorphisms of IL23R and Fuchs' syndrome in a Chinese Han population. | 2010 | 13 |
| 11 | 2016 | 12 | |
| 12 | 2010 | 9 | |
| 13 | 2016 | 7 | |
| 14 | 2022 | 5 | |
| 15 | CD40 polymorphisms in Han Chinese patients with Fuch uveitis syndrome. | 2011 | 4 |
| 16 | 2020 | 4 | |
| 17 | PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. | 2019 | 3 |
| 18 | 2018 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2016 | 1 |
About Feilan Chen
Feilan Chen is a scholar working on Ophthalmology, Genetics, Hematology, Molecular Biology and Sensory Systems, having authored 24 papers that have together received 523 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (11 papers), Erythropoietin and Anemia Treatment (2 papers), Glioma Diagnosis and Treatment (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Industrial and Mining Safety (1 paper), Lung Cancer Treatments and Mutations (1 paper), Traumatic Brain Injury and Neurovascular Disturbances (1 paper) and Renal Diseases and Glomerulopathies (1 paper). The work is most often cited by research in Ophthalmology (98 citations), Genetics (42 citations), Cancer Research (61 citations), Drug Discovery (1 citation) and Biomaterials (43 citations). Feilan Chen has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Zhaohua Tang, Zili Liu, Yongguo Li, Yan Chen, Jie Gao, Shengping Hou, Peizeng Yang, Aize Kijlstra, Fuzhen Li and Zhengxuan Jiang. Their work appears in journals such as Frontiers in Immunology, Journal of Neuro-Oncology, Lara D. Veeken, Cancer Cell International and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.